ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2.
In mutant superoxide dismutase (SOD1)-linked amyotrophic lateral sclerosis (ALS), accumulation of misfolded mutant SOD1 in spinal cord mitochondria is thought to cause mitochondrial dysfunction. Whether mutant SOD1 is toxic per se or whether it damages the mitochondria through interactions with other mitochondrial proteins is not known. We previously identified Bcl-2 as an interacting partner of mutant SOD1 specifically in spinal cord, but not in liver, mitochondria of SOD1 mice and patients. We now show that mutant SOD1 toxicity relies on this interaction. Mutant SOD1 induces mitochondrial morphological changes and compromises mitochondrial membrane integrity leading to release of Cytochrome C only in the presence of Bcl-2. In cells, mouse and human spinal cord with SOD1 mutations, the binding to mutant SOD1 triggers a conformational change in Bcl-2 that results in the uncovering of its toxic BH3 domain and conversion of Bcl-2 into a toxic protein. Bcl-2 carrying a mutagenized, non-toxic BH3 domain fails to support mutant SOD1 mitochondrial toxicity. The identification of Bcl-2 as a specific target and active partner in mutant SOD1 mitochondrial toxicity suggests new therapeutic strategies to inhibit the formation of the toxic mutant SOD1/Bcl-2 complex and to prevent mitochondrial damage in ALS.
Pedrini
Steve
S
Frances and Joseph Weinberg Unit for ALS Research, Farber Institute for Neurosciences, Department of Neuroscience, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Sau
Daniela
D
Guareschi
Stefania
S
Bogush
Marina
M
Brown
Robert H
RH
Naniche
Nicole
N
Kia
Azadeh
A
Trotti
Davide
D
Pasinelli
Piera
P
D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology* / Q000235:genetics* / Q000473:pathology; D000818:Animals; D002460:Cell Line; D002470:Cell Survival; D006801:Humans; D051379:Mice; D008818:Mice, Neurologic Mutants; D008928:Mitochondria / Q000473:pathology* / Q000648:ultrastructure; D050505:Mutant Proteins / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D017434:Protein Structure, Tertiary; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000737:chemistry* / Q000633:toxicity; D013482:Superoxide Dismutase / Q000235:genetics* / Q000633:toxicity
D050505:Mutant Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D013482:Superoxide Dismutase
J Biol Chem. 2007 Oct 5;282(40):29296-304
17690097
Nature. 1993 Mar 4;362(6415):59-62
8446170
J Neurosci. 2006 Aug 23;26(34):8774-86
16928866
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13901-6
11095709
Nat Rev Neurosci. 2009 Jul;10(7):481-94
19543220
Nat Rev Neurosci. 2006 Sep;7(9):710-23
16924260
J Neurosci. 2002 Mar 15;22(6):RC215
11886899
Antioxid Redox Signal. 2009 Jul;11(7):1615-26
19344253
Science. 2004 Feb 13;303(5660):1010-4
14963330
Antioxid Redox Signal. 2008 Mar;10(3):405-43
18370853
J Biol Chem. 2008 Oct 17;283(42):28321-8
18715867
BMC Neurosci. 2003 Jul 15;4:16
12864925
Neuron. 2004 Jul 8;43(1):19-30
15233914
Mitochondrion. 2005 Apr;5(2):77-87
16050975
Antioxid Redox Signal. 2009 Jul;11(7):1535-45
19344250
J Neurosci. 2005 Jan 5;25(1):164-72
15634778
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15763-8
9861044
Physiol Rev. 2007 Jan;87(1):99-163
17237344
Semin Cancer Biol. 2009 Feb;19(1):42-9
19138742
Exp Neurol. 2009 Aug;218(2):203-12
19341732
Biochemistry. 2004 May 4;43(17):4899-905
15109247
Cancer Cell. 2008 Oct 7;14(4):285-98
18835031
J Neurochem. 2009 Feb;108(3):578-90
19046404
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11357-62
9326614
Adv Exp Med Biol. 1996;406:99-112
8910675
EMBO J. 1998 Aug 10;17(5):1268-78
9482724
Science. 1997 Dec 12;278(5345):1966-8
9395403
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2007-11
19174508
Acta Neuropathol. 2001 Oct;102(4):293-305
11603803
Annu Rev Neurosci. 2004;27:723-49
15217349
J Neurochem. 2006 Mar;96(5):1349-61
16478527
Int J Biochem Cell Biol. 2009 Oct;41(10):1884-9
19439192
J Neurosci Methods. 2002 Mar 15;114(2):165-72
11856567
Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):4022-7
18296640
Neuron. 2004 Jul 8;43(1):5-17
15233913
Oncogene. 2006 Aug 7;25(34):4725-43
16892086
FASEB J. 2006 Oct;20(12):2147-9
16935937
Cell. 2004 Feb 20;116(4):527-40
14980220
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5113-8
9144199
Science. 1997 Jul 25;277(5325):559-62
9228005
J Neurosci. 1998 May 1;18(9):3241-50
9547233
Leukemia. 2001 Jun;15(6):869-74
11417471
Neuron. 1995 Jun;14(6):1105-16
7605627
J Biol Chem. 2002 Aug 16;277(33):29626-33
12050154
J Biol Chem. 2001 Oct 19;276(42):38388-93
11507097
J Neurosci. 2000 Dec 15;20(24):9119-25
11124989
J Cell Mol Med. 2009 Jun;13(6):1004-33
19220575